Regulators of Genetic Risk for the Progression of Non-alcoholic Fatty Liver Disease to Hepatocellular Carcinoma: Reconstruction of Transcriptional Network and Signature-Based Metabolic Profiling
- 1 December 2022
- book chapter
- Published by Springer Nature
- p. 193-227
Abstract
No abstract availableKeywords
This publication has 109 references indexed in Scilit:
- NCBI GEO: archive for functional genomics data sets—updateNucleic Acids Research, 2012
- Integrative Genomic Identification of Genes on 8p Associated With Hepatocellular Carcinoma Progression and Patient SurvivalGastroenterology, 2012
- Combining Clinical, Pathology, and Gene Expression Data to Predict Recurrence of Hepatocellular CarcinomaGastroenterology, 2011
- What is flux balance analysis?Nature Biotechnology, 2010
- Activation of nuclear receptor CAR ameliorates diabetes and fatty liver diseaseProceedings of the National Academy of Sciences, 2009
- The Constitutive Androstane Receptor Is an Anti-obesity Nuclear Receptor That Improves Insulin SensitivityJournal of Biological Chemistry, 2009
- Effects of Liver Biopsy Sample Length and Number of Readings on Sampling Variability in Nonalcoholic Fatty Liver DiseaseClinical Gastroenterology and Hepatology, 2009
- Gene Expression in Fixed Tissues and Outcome in Hepatocellular CarcinomaNew England Journal of Medicine, 2008
- Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver diseaseNature Genetics, 2008
- Gene set enrichment analysis: A knowledge-based approach for interpreting genome-wide expression profilesProceedings of the National Academy of Sciences, 2005